BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22341560)

  • 1. Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signaling pathway.
    Wang Y; Yang Y; Liu X; Wang N; Cao H; Lu Y; Zhou H; Zheng J
    Cell Immunol; 2012; 274(1-2):121-9. PubMed ID: 22341560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling.
    Tanimura N; Saitoh S; Matsumoto F; Akashi-Takamura S; Miyake K
    Biochem Biophys Res Commun; 2008 Mar; 368(1):94-9. PubMed ID: 18222170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14.
    Watanabe S; Kumazawa Y; Inoue J
    PLoS One; 2013; 8(4):e60078. PubMed ID: 23565187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
    Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
    Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
    Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
    J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14, TLR4 and TRAM Show Different Trafficking Dynamics During LPS Stimulation.
    Klein DC; Skjesol A; Kers-Rebel ED; Sherstova T; Sporsheim B; Egeberg KW; Stokke BT; Espevik T; Husebye H
    Traffic; 2015 Jul; 16(7):677-90. PubMed ID: 25707286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling.
    Van Acker T; Eyckerman S; Vande Walle L; Gerlo S; Goethals M; Lamkanfi M; Bovijn C; Tavernier J; Peelman F
    J Biol Chem; 2014 Jan; 289(3):1364-76. PubMed ID: 24297182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIF signaling is essential for TLR4-driven IgE class switching.
    Janssen E; Ozcan E; Liadaki K; Jabara HH; Manis J; Ullas S; Akira S; Fitzgerald KA; Golenbock DT; Geha RS
    J Immunol; 2014 Mar; 192(6):2651-8. PubMed ID: 24532577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages.
    Qi HY; Shelhamer JH
    J Biol Chem; 2005 Nov; 280(47):38969-75. PubMed ID: 16176925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A2 binds to endosomes and negatively regulates TLR4-triggered inflammatory responses via the TRAM-TRIF pathway.
    Zhang S; Yu M; Guo Q; Li R; Li G; Tan S; Li X; Wei Y; Wu M
    Sci Rep; 2015 Nov; 5():15859. PubMed ID: 26527544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM.
    Wang L; Trebicka E; Fu Y; Waggoner L; Akira S; Fitzgerald KA; Kagan JC; Cherayil BJ
    J Innate Immun; 2011; 3(5):437-46. PubMed ID: 21494017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raftlin Controls Lipopolysaccharide-Induced TLR4 Internalization and TICAM-1 Signaling in a Cell Type-Specific Manner.
    Tatematsu M; Yoshida R; Morioka Y; Ishii N; Funami K; Watanabe A; Saeki K; Seya T; Matsumoto M
    J Immunol; 2016 May; 196(9):3865-76. PubMed ID: 27022195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.
    Yurchenko M; Skjesol A; Ryan L; Richard GM; Kandasamy RK; Wang N; Terhorst C; Husebye H; Espevik T
    J Cell Biol; 2018 Apr; 217(4):1411-1429. PubMed ID: 29440514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disabled-2 is a negative immune regulator of lipopolysaccharide-stimulated Toll-like receptor 4 internalization and signaling.
    Hung WS; Ling P; Cheng JC; Chang SS; Tseng CP
    Sci Rep; 2016 Oct; 6():35343. PubMed ID: 27748405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid raft-dependent endocytosis negatively regulates responsiveness of J774 macrophage-like cells to LPS by down regulating the cell surface expression of LPS receptors.
    Józefowski S; Śróttek M
    Cell Immunol; 2017 Feb; 312():42-50. PubMed ID: 27908440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway.
    Palsson-McDermott EM; Doyle SL; McGettrick AF; Hardy M; Husebye H; Banahan K; Gong M; Golenbock D; Espevik T; O'Neill LA
    Nat Immunol; 2009 Jun; 10(6):579-86. PubMed ID: 19412184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins.
    Bonhomme D; Santecchia I; Vernel-Pauillac F; Caroff M; Germon P; Murray G; Adler B; Boneca IG; Werts C
    PLoS Pathog; 2020 Aug; 16(8):e1008639. PubMed ID: 32790743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.